apollo
logo
0Login
Introducing Our Latest Arrival!
Rozglyn-MP1 Tablet 10's

Rozglyn-MP1 Tablet 10's

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Bilberry Pharmaceutical Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-26

for this medicine

About Rozglyn-MP1 Tablet

Rozglyn-MP1 Tablet belongs to a class of medicines called anti-diabetic drugs used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. Type 2 diabetes is a chronic (long-lasting) condition that affects the way our body processes glucose. People with type 2 diabetes either do not produce enough insulin or the insulin produced is unable to perform its function in the body (insulin resistance).

Rozglyn-MP1 Tablet is a combination of three antidiabetic drugs, namely: Glimepiride, Metformin, and Pioglitazone. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle, and fat cells to insulin and enables cells to remove glucose from blood more effectively. Thereby, Rozglyn-MP1 Tablet helps to control blood sugar levels.

Take Rozglyn-MP1 Tablet as prescribed by your doctor. You are advised to take Rozglyn-MP1 Tablet for as long as your doctor has prescribed it for you based on your medical condition. In some cases, you may experience stomach pain, nausea, diarrhoea, vomiting, headache, metallic taste, or low blood sugar. Most of these side effects of Rozglyn-MP1 Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

If you are allergic to Rozglyn-MP1 Tablet or any other medicines, please tell your doctor. Rozglyn-MP1 Tablet is not recommended for children. Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in human milk. If you are pregnant or planning for pregnancy, please inform your doctor before taking Rozglyn-MP1 Tablet as it may harm the unborn baby. Rozglyn-MP1 Tablet should be used with caution in elderly patients. Avoid alcohol consumption with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking Rozglyn-MP1 Tablet .

Uses of Rozglyn-MP1 Tablet

Treatment of Type 2 diabetes mellitus

Medicinal Benefits

Rozglyn-MP1 Tablet contains three antidiabetic drugs (Glimepiride, Metformin and Voglibose) used in the treatment of type 2 diabetes. Glimepiride stimulates cells in the pancreas that produce insulin which helps to remove sugar from the blood. Metformin reduces the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle and fat cells to insulin and enables cells to remove glucose from blood more effectively. Also, it decreases the amount of glucose produced by the liver and preserves the functioning of beta cells in the pancreas that produces insulin. Thereby, Rozglyn-MP1 Tablet helps to control blood sugar levels.

Directions for Use

Take Rozglyn-MP1 Tablet with food to avoid stomach upset, or take it as advised by your doctor. Swallow it as a whole with a glass of water. Do not crush or break it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Rozglyn-MP1 Tablet

  • Stomach pain
  • Nausea
  • Diarrhoea
  • Vomiting
  • Headache
  • Metallic taste
  • Low blood sugar

Drug Warnings

If you are allergic to Rozglyn-MP1 Tablet or any other medicines, please tell your doctor. Rozglyn-MP1 Tablet is not recommended for children. Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in human milk. If you are pregnant or planning for pregnancy, please inform your doctor before taking Rozglyn-MP1 Tablet as it may harm the unborn baby. Rozglyn-MP1 Tablet should be used with caution in elderly patients. Avoid alcohol consumption with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body). Drive only if you are alert after taking Rozglyn-MP1 Tablet . Take short, frequent meals and avoid prolonged fasting while taking Rozglyn-MP1 Tablet . Beware of symptoms of hypoglycemia (low blood sugar) which include sweating, dizziness, palpitations, shivering, intense thirst, dry mouth, dry skin, frequent urination, etc. Whenever you experience any of these symptoms, immediately consume 5-6 candies or 3 glucose biscuits, or 3 teaspoons of honey/sugar, and also consult your doctor. Make sure to carry these with you at all times, especially during long travels.

Drug Interactions

Drug-Drug Interaction: Rozglyn-MP1 Tablet may have interaction with other antidiabetic drugs (insulin, sitagliptin, empagliflozin), water pill (furosemide), antithyroid drugs (levothyroxine), anticonvulsant (pregabalin).

Drug-Food Interaction: Rozglyn-MP1 Tablet may interact with alcohol. Therefore, avoid the consumption of alcohol with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).

Drug-Disease Interaction: If you have bladder cancer, uncontrolled diabetes, lactic acidosis, diabetic ketoacidosis (accumulation of ketone bodies in the blood), or eye problems caused by diabetes, liver, kidney, or heart problems, inform your doctor before taking Rozglyn-MP1 Tablet .

Drug-Drug Interactions Checker List

  • INSULIN
  • SITAGLIPTIN
  • EMPAGLIFLOZIN
  • FUROSEMIDE
  • LEVOTHYROXINE
  • PREGABALIN

Habit Forming

No

Diet & Lifestyle Advise

  • Do regular exercise such as cycling, walking, jogging, dancing or swimming for a minimum of 30 minutes per day. Invest at least 150 minutes of your week in exercise.

  • Maintain healthy body weight as obesity is also related to the onset of diabetes.

  • Maintain a low fat and a low sugar diet. Replace carbohydrates-containing foods with whole grains, fruits and vegetables as carbohydrates turn to sugars leading to high blood sugar.

  • Avoid consumption of alcohol and quit smoking.

Special Advise

Regular blood tests are recommended while taking Rozglyn-MP1 Tablet to monitor blood sugar levels.

Disease/Condition Glossary

Type 2 diabetes: It is a chronic (long-lasting) condition that keeps the body away from properly utilizing insulin. Hence, people affected with type 2 diabetes either do not produce enough insulin, or there is resistance to the action of insulin. Middle-aged or older are most likely to suffer from type 2 diabetes, so it is also known as adult-onset diabetes. Symptoms of type 2 diabetes include frequent urination at night, increased thirst, slow wound healing, increased hunger, fatigue, and blurred vision. In some cases, there may be weight gain while in rare cases weight loss may be observed. The complication of type 2 diabetes also includes nerve problems, kidney problems, damaged retina of eyes or blindness, loss of limbs, sexual dysfunction, and increase chance of heart attack or stroke.

bannner image

Alcohol

Unsafe

You are recommended to avoid consumption of alcohol with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).

bannner image

Pregnancy

Unsafe

Rozglyn-MP1 Tablet is not recommended for pregnant women as it may harm an unborn baby. Please consult a doctor if you are pregnant or planning for pregnancy.

bannner image

Breast Feeding

Unsafe

Avoid breastfeeding while taking Rozglyn-MP1 Tablet as it may be excreted in breastmilk and cause adverse effects in the baby. Therefore, please consult a doctor before using Rozglyn-MP1 Tablet if you are breastfeeding.

bannner image

Driving

Caution

Rozglyn-MP1 Tablet may decrease alertness in some people. Therefore, drive only if you are alert after taking Rozglyn-MP1 Tablet .

bannner image

Liver

Caution

Take Rozglyn-MP1 Tablet with caution, especially if you have a history of Liver diseases/conditions. The dose may be adjusted by your doctor as required.

bannner image

Kidney

Caution

Take Rozglyn-MP1 Tablet with caution, especially if you have a history of Kidney diseases/conditions. The dose may be adjusted by your doctor as required.

bannner image

Children

Unsafe

Rozglyn-MP1 Tablet is not recommended for children as the safety and effectiveness were not established.

Country of origin

India
Other Info - ROZ0509

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Rozglyn-MP1 Tablet is used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone.
Rozglyn-MP1 Tablet contains Glimepiride, Metformin and Pioglitazone. Glimepiride works by stimulating beta cells in the pancreas that produce insulin. Thus, insulin helps to remove sugar from the blood. Metformin works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the sensitivity of muscle cells to insulin which enables these cells to remove sugar more effectively from the blood. Pioglitazone works by increasing the sensitivity of liver, muscle and fat cells to insulin and enables cells to remove glucose from blood more effectively. Thereby, Rozglyn-MP1 Tablet helps to control blood sugar levels.
Rozglyn-MP1 Tablet may increase the risk of low blood sugar levels especially with alcohol intake, when you exercise more than usual, delay or miss snacks or meal. However, if you experience any signs of low blood pressure such as dizziness, nausea, light-headedness, dehydration or fainting, please consult a doctor.
You are not recommended to take Rozglyn-MP1 Tablet with pregabalin as it may cause weight gain and fluid retention that could lead to heart failure. However, please consult a doctor before using Rozglyn-MP1 Tablet with other medicines.
In type 1 diabetes, the body doesn’t produce insulin as the islet cells (insulin-producing cells) in the pancreas are destroyed completed. In type 2 diabetes, though islet cells are working, the body doesn’t respond to insulin as the body becomes resistant to insulin.
You are not recommended to stop taking Rozglyn-MP1 Tablet on your own as discontinuing Rozglyn-MP1 Tablet suddenly may cause recurring symptoms or worsen the condition. However, if you experience any difficulty while taking Rozglyn-MP1 Tablet , please consult your doctor so that alternative medicine may be prescribed.
Yes, Rozglyn-MP1 Tablet may cause stomach upset as a side effect. Drink water/fluids in small, frequent amounts and chew the food properly while eating.
You are recommended to avoid consumption of alcohol with Rozglyn-MP1 Tablet as it may increase the risk of lactic acidosis (accumulation of lactic acid in the body).
Inform the doctor if you are taking any other medicines, have any other medical conditions, and if you are pregnant or breastfeeding.
Yes, Rozglyn-MP1 Tablet may lead to vitamin B12 deficiency, particularly on long-term use. Consult the doctor if you experience symptoms of vitamin b12 deficiency such as headache, loss of appetite, fatigue, mental impairment, pins and needle sensation, and pale skin.
Store Rozglyn-MP1 Tablet at room temperature, in a dry place. Keep out of sight and reach of children.
Rozglyn-MP1 Tablet may cause side effects like stomach pain, nausea, diarrhoea, vomiting, headache, metallic taste, or low blood sugar. If the side effects persist or worsen, please consult your doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.